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ABSTRACT
Neurological disorders (NDDs), like Fragile X Syndrome (FXS), are becoming more
prevalent. One outstanding question in the field is how genetic risk factors for NDDs, like Fmr1,
converge with environmental risk factors like bisphenol A (BPA). Our research compares and
contrasts the different molecular impacts of BPA exposure in wild-type and FXS flies using
mRNA-sequencing analysis. This analysis identifies the mutation in the Fmr1 gene is shown to
have a stronger effect on the Drosophila than the presence of BPA, resulting in significant
differential gene expression that perturbed several neurological pathways. Moreover, numerous
genes responsible for genetic human diseases have homologs in flies. Hence, this analysis has the
potential to help better understand and identify novel therapeutic targets.

Keywords - Bisphenol A (BPA), Fragile X Syndrome (FXS), Drosophila melanogaster, Fmr1
gene, mRNA Sequencing, Differential Expression (DE)
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1

INTRODUCTION

Studies have indicated that the environmental factor, bisphenol A (BPA), may be a risk
factor for neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and
attention deficit hyperactivity disorder (ADHD) [1]. Despite the environmental prevalence of
BPA, there is a lack of understanding of the molecular impacts of BPA in humans. In particular,
individuals with an NDD may be impacted differently due to exposure to BPA. With nearly 75
million people worldwide and with 1 in 44 children in the United States diagnosed with ASD or
autism alone, the molecular mechanisms behind BPA exposure are critical to the understanding
of molecular etiologies of NDDs and to identify better therapeutic approaches. This research
hopes to address this question using a fruit fly (Drosophila melanogaster or Drosophila for
short) model of fragile X syndrome (FXS) to analyze the effects of BPA exposure.

II.

BACKGROUND

2. 1 Biological Background
2.1.1 BPA
The environmental chemical BPA is a phenol; a phenol is a chemical that contains an
-OH group [2, 3, 4]. The -OH group allows BPA to react rapidly with other molecules to produce
a stable synthetic polymer. These polymers are used to make nearly 2.7 million tons of
manufactured products annually, such as polycarbonate plastics, epoxy resins, and thermal
papers. Hence, items in our everyday life, like water pipes and aluminum cans, contain BPA.
The presence of BPA in these items protects the material inside from environmental
contaminants [2, 3, 4]. For example, in products such as aluminum cans, plastic bottles, and food
containers, the BPA protects the stored foods and liquids from being exposed to air. BPA’s
presence also helps plastic containers hold their different shapes.
2.1.2 Ingestion of BPA
With the increased prevalence of BPA, people are exposed to the chemical from the dust
in the atmosphere to the food they ingest [5]. The BPA used to synthesize plastics and epoxy
resins can be found in various common products like canned beverages, canned foods, and
plastic food containers [5, 6]. The BPA from these products infuses into the food and drinks that
are ingested [5, 6]. Foods that are stored when they are hot or foods that have been stored for
extended periods of time have higher concentrations of BPA [5, 6]. In extreme conditions, like
high temperature or alkalinity, the stable BPA in the polymers breaks down more readily [5, 6].
Moreover, infants, especially during their first three months, ingest the highest levels of
BPA compared to humans of different ages because a newborn's diet is mainly stored in plastic
containers and sippy cups [4]. This heightened exposure at such an early age could be one of the
reasons for the correlation between BPA exposure and NDDs in children.
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2.1.3 Effects of BPA on Pregnancy
BPA exposure during pregnancy is correlated with harmful effects. Women's estrogen
levels are incredibly high during pregnancy since estrogen is required to produce several female
characteristics [7]. However, BPA is a synthetic xenoestrogen or a chemical with a structure
similar to estrogen. Exposure to BPA during this time could mean that BPA could replace
estrogen and potentially cause adverse effects for the mother and the fetus.
In a study with another model organism, Caenorhabditis elegans, the effects of BPA
during pregnancy led to the zygote’s chromosomes not separating properly [8]. This creates an
improperly split single daughter cell instead of two separate daughter cells, leading to the death
of the embryo during the early stages of the pregnancy. The study also cites other studies with
mice, which illustrate similar results. Early embryonic lethality in both species indicates a
commonality that could also be present in humans.
Moreover, a known role of estrogen is to repair DNA breaks [7, 8]. A study found that
there are significantly more double-stranded breaks in the DNA when it is exposed to BPA. The
study also shows that BPA does not cause actual breaks but stops the production of the genes
used in DNA repair. Therefore, BPA exposure during pregnancy can create irreparable
double-stranded breaks that could lead to miscarriages, risks during pregnancy, or children born
with complications like NDDs.
Estrogen is an important hormone that is also involved in brain development. Estrogen
maintains the neural connection between different brain parts; if this gets disrupted due to BPA,
it could lead to neurological diseases [8]. The Elsworth et al. study supports this by showing that
prenatal exposure in rodents led to changes in dopamine levels in the midbrain and synaptic
junctions in the hippocampus [9]. The study also notices the degradation of the midbrain and the
synapses in the hippocampus in non-human primates [9]. Therefore, BPA affects neuron
junctions [9]. This research shows that exposure during pregnancy to BPA can lead to improper
formation of the midbrain, especially the hippocampus, leading to neurological problems [9].
2.1.4 BPA correlation To Autism and FXS
ASD is a spectrum disorder with many subtypes and is influenced by both genetic and
environmental factors [10]. Autism is a developmental disability caused by differences in the
brain leading to problems with socialization and restricted or repetitive behaviors [10]. Two
common symptoms of autism are learning defects and the inability to understand emotions [10].
As mentioned earlier, BPA affects the hippocampus, a brain region involved with learning and
emotions [9, 11]. Hence, BPA could be one of the causes of autism.
Fragile X syndrome (FXS) affects nearly one in every 4,000 men and one in every 6,000
women [12]. The gene that causes FXS is the most common single gene cause of autism,
accounting for nearly 5% of autistic cases. Due to the prevalence of autism in FXS, scientists
believe understanding FXS will lead to significant findings in autism.
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An increase of CGG repeats in the 5’ UTR region (as shown in Figure 1) of the Fmr1
gene causes FXS [12]. The Fmr1 gene encodes the fragile X mental retardation protein (FMRP).
This protein is used for a number of critical roles in neurons, including translational regulation of
mRNA, trafficking mRNA, and regulation of ion channels. Typically, people have less than 54
CGG repeats; people with a full mutation have more than 200 repeats with no protein production.
Some people have 55 to 200 repeats where less protein is made; this is a premutation.

Figure 1. Difference between Normal and Fragile X-Syndrome X Chromosome
Source: Adapted from [13]

2.2 Sequencing Background
This project will use mRNA sequencing to determine the differentially expressed genes
and pathways impacted due to BPA exposure in Drosophila melanogaster modeled with and
without FXS.
2.2.1 mRNA sequencing Background
The central dogma is the process of transcribing the DNA to messenger RNA (mRNA)
and translating the mRNA into protein [13]. (Not all parts of the DNA get translated into
mRNA.) In mRNA sequencing, the mRNA is measured to determine the protein expression in
the cell. The first step is to extract the mRNA from the other molecules in the cell. mRNA is
unique from the other types of RNA because it has a poly-A tail or several adenine nucleotides.
Therefore, by complementing the poly-A tail with poly-T oligos (attached to a bead), mRNA can
be extracted from the rest of the molecules.
However, RNA is a single-stranded sequence, making it more inclined to degradation;
therefore, these extracted mRNA strands are converted to stable double-stranded DNA through
reverse transcription [13]. The synthesized DNA is called complementary DNA (cDNA).
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Next-generation sequencing (NGS) utilizes a parallelization technique to sequence these
cDNA strands using a process called sequencing by synthesis (SBS) [14]. During this process,
adapters (which contain primers for polymerase chain reaction (PCR), an index sequence, and a
complementary sequence to the flow cell) are added to the strands, and the sequences are PCR
amplified. Illumina also offers the choice to sequence one or both ends of the cDNA. It is often
better to sequence both ends to have a higher alignment accuracy. One of the downsides of NGS
is that it can only process strands that are 50 to 250 base pairs long, so the cDNA strands are
fragmented.
2.2.2 mRNA Sequencing Analysis Background
Quality Check
Quality check of the raw reads is essential to determine the quality of the reads and the
quality of the bases in the reads; moreover, quality checks such as GC% content, base sequence
content, and N base content will also provide insight into any contamination that is present in the
samples. Moreover, due to SBS, not all strands are sequenced at the same rate; these errors in
phasing result in low-quality reads [15].
FastQC is a quality check program that produces a report with several quality check
metrics in a graphical format [16]. These graphs include information about the overall quality of
the bases, adapter content in the reads, and sequence duplication levels. FastQC produces a
report for each sample file. To visualize and understand multiple FastQC reports, a tool called
MultiQC was developed, which combines all the results into one report.
Trimming Raw Reads
After the quality check of the raw reads, the pre-processing step of trimming is
conducted. During the trimming step, these low-quality reads and bases are identified and
removed to ensure that the internal quality of the reads has a high Phred score [15]. Trimming is
also required to remove the adapters that were added to the ends of the reads during NGS [17]. A
critical aspect of trimming to remember is that the more stringent the trimming, the fewer reads
are left to do further analysis with. While trimming might be highly beneficial by providing the
highest quality reads, it is important to ensure that a significant amount of the reads are protected
for downstream analysis [17].
Fastp tool is an all-processing tool that can automatically trim the raw reads without
additional parameters. Moreover, this process happens two to five times faster than other
trimming tools, such as Trimmomatic, since it is written in C++ and supports multithreading
[18].
Transcript Assembly
There are two types of assembly. The first type of assembly is called de novo assembly,
which uses overlapping reads to determine the organisms’ genome [19]. The second type of
assembly involves aligning the reads to a reference genome, which is available for humans and
several model organisms. After trimming, the reads need to be “assembled” together to the
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Drosophila melanogaster genome to determine which genes are differentially expressed. This
process considers the order and orientation of the reads as well as any overlaps between the
reads.
The biggest challenge with reconstruction is the fact that the reads are short in nature
[19]. Therefore, it is hard to precisely align them given that the genome is full of duplications.
Moreover, several reads can come from the same gene loci due to alternative splicing. Different
isoforms code for other proteins; hence, reads from different mRNA strands align to the same
gene loci.
One tool to conduct alignment is the Spliced Transcripts Alignment to a Reference
(STAR); STAR is designed to combat the splicing problem and has high accuracy, despite its
memory problems [20, 21]. STAR utilizes a two-step process: 1) seed searching and 2)
clustering, stitching, and scoring, to stitch and map the reads. The different steps of STAR are
depicted in Figure 2.

Figure 2. STAR methods
Source: Adapted from [20]
PCR Duplication Removal
The removal of duplicates has been a traditional part of the mRNA-sequencing analysis
since it increases the quality of the individual reads [22]. Although this step reduces the number
of properly paired mapped reads, it provides a better accuracy in identifying differentially
expressed (DE) genes and pathways. Dozmorov et al. show that when coupled with adapter
trimming, this step determines significant biological signals more confidently.
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In contrast, the Parekh et al. study shows how duplicate reads are necessary for
differential gene expression (DGE) analysis [23]. Because duplicates remove sampling bias and
fragmentation bias, duplicates ensure that there are no false positives. In their experiment, the
removal of duplicates worsened the statistical power and False Discovery Rate (FDR) while
providing no improvement in accuracy and precision. One thing to note is that their experiment
uses single-end reads, which are highly influenced by fragmentation bias that occurs during
NGS.
Picard is a collection of open-source command line tools in Java to manipulate and
analyze sequence tools; MarkDuplicates, a tool in Picard, identifies duplicates in the reads [24,
25]. These duplicates include those that are created from PCR sequencing and those from the
incorrect identification of the clusters during NGS.
Counting the Reads
Before DGE analysis can be performed, the read coverage for each “region” of interest
needs to be determined [26]. Due to alternative splicing, there are two ways to count the reads;
the “region” can either refer to an individual exon (where the read overlaps in each exon are
counted) or the whole gene (where all reads that overlap any of the exons of the gene are
counted). One problem with looking at the entire gene for reads is that this process does not
differentiate between the different isoforms; this is solved using gene annotations from RefSeq or
Ensembl. Other things that need to be accounted for include indels, duplications, and other
complications that might occur when comparing the location to the “region” of the genome. By
using machine learning techniques such as feature extraction and chromosome hashing,
featureCounts can speed up the process of counting the reads. featureCounts is a program built in
C with many capabilities, including multithreading.
Differential Gene Expression
DGE analysis is used to determine the differences in gene expression between the
different treatments and conditions by measuring the read counts [27]. DESeq2 is an open-source
DGE analysis program that allows its results to be easily shown through graphical visualizations
[28, 29, 30]. DESeq2 assumes that the non-DE genes will have similar variances and expression
levels. After normalizing the reads, the DE genes between the two samples can be determined
using pairwise comparisons.
Pairwise comparisons are conducted using a Wald test, a method of hypothesis testing
that determines if the read counts for each gene are significant [28, 29, 30]. The Wald test
determines the probability that the most extreme values observed happened by chance or the
p-value. If this p-value is small, then the test states that the gene is DE, else the gene is not DE.
After DESeq2 is completed, a dataframe is returned with the DE genes, their base mean, the log2
fold change, the log2 fold change standard error, the p-value, and the p-adjusted value. The base
mean refers to the mean of the normalized counts for both samples. The log2 fold change is the
log comparison of the read counts of the treatment compared to the control. The p-value is
calculated from the Wald test, and the adjusted p-value refers to the Benjamini-Hochberg
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adjusted p-value, which reduces false positives or genes that are falsely determined to be
significant.
Pathway Analysis
Gene set enrichment analysis (GSEA) is a method that analyzes a set of statistically
ranked genes to determine the pathways that are affected [31]. GSEA utilizes the Molecular
Signature Database (MSigDB), which contains tens of thousands of annotated gene sets in
humans and mice. In the human collection, there is a category called Ontology Gene Set (C5 or
GO), which is a collection meant to unify the genes and gene attributes among different species,
including the Drosophila melanogaster.
The GO collection contains information about biological processes, molecular functions,
and cellular components [31]. Biological processes refer to processes that are vital for the
organism to survive and interact with its environment. Molecular functions are the functions that
the protein can do when it interacts with a molecule, such as another protein, water, or DNA. The
cellular components are the cellular structures of a cell. Using these databases and collections,
pathways that influence the biological processes (BP), molecular functions (MF), and cellular
components (CC) can be determined from the ranked list of genes. Fast gene set enrichment
analysis (FGSEA) is an R-package that calls GSEA for the genes from DESeq2 that are ranked
according to the p-adjusted value [32].
In comparison, Database for Annotation Visualization and Integrated Discovery (DAVID)
provides similar functional annotation tools like GSEA [33, 34]. DAVID uses an agglomeration
algorithm and a heuristic clustering algorithm to condense the genes, and biological terms into
functional groups called biological modules. Normally, several hundred or thousands of genes
are required to identify the biological processes by classifying the genes into these biological
modules. However, DAVID clusters genes by sequences that are similar to each other or have
similar protein domains. Classically, three assumptions are made during the clustering of genes:
1) all genes must be part of a cluster, 2) a gene only belongs to one cluster, and 3) a cluster can
be of varying sizes (to account for outliers). DAVID avoids these assumptions by using a
heuristic fuzzy multiple-linkage clustering algorithm. It believes genes should be grouped into
functional groups rather than just grouping similar sequences. Since a single gene can have
multiple functions, it is allowed to belong to multiple clusters. Moreover, only similar genes are
clustered together, removing outliers and genes that are overall irrelevant to the function of the
cluster.
Workflow Management
The computational workflow is managed using a Python-based program called
Snakemake, a Python-based program that automates an analysis pipeline [35]. This workflow
system has a recognition mechanism that allows the system only to rerun the programs where
any changes have occurred. Each of these steps is defined as a rule with input and output files, as
well as additional parameters and individualized environment files for consistency. Therefore,
Snakemake ensures that the pipeline is both scalable and reproducible with these configuration
files.
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METHODS AND MATERIALS

3.1 Biological Processes
Since people with FXS cannot produce the protein FMRP, Drosophila melanogaster is
manipulated to carry a null mutation in Fmr1 that would prevent its expression. Drosophila is a
good model organism as it has a short lifespan, is genetically tractable, and is easy to maintain in
the laboratory [35, 36]. Importantly, fruit flies have a functional ortholog to the human FMR1
gene, meaning the Drosophila Fmr1 gene is a conserved sequence, and its function is similar in
humans. Thus, FXS could be modeled in fruit flies.
Wild-type and Fmr1 Drosophila
The wild-type strain that was used was the w118 strain from the Bloomington Stock
Center. It was stored at 25℃ with a twelve-hour day/night cycle [36, 37]. The Fmr1 strain was
the dFmr13 line provided by Dr. Thomas Jongens from the University of Pennsylvania; it was
created from the w118 strain by removing a transposable element in the 5’ UTR to create the
FXS mutation.
BPA Exposure
The Drosophila were exposed to BPA through food at a concentration of 1 mM and were
compared to flies reared in food lacking BPA (the control) [36, 37]. BPA was dissolved in water
and then used to cook the cornmeal-yeast-agar fly food mixture. Virgin female flies were taken
and placed in the BPA-food vials for four days before the introduction of males. This ensures that
the female oocytes (eggs) are exposed to BPA, enabling embryonic exposure to BPA. The parent
(P1) generation is removed, and then after seven days, 40 of the first filial (F1) larvae were
collected for sequencing for each sample.
3.1.1 Sequencing and Data
Paired-end sequencing (150 bp x 2) were performed on twenty-four samples by
GeneWiz, a sequencing company, using the Illumina technique mentioned above [38]. There
were three biological replicates for each treatment and condition: Fragile X syndrome (fmr1)
flies with and without BPA and wild-type (WT) flies with and without BPA. The samples that
were sequenced are described in more detail in Table 1, along with the yields of the individual
replicates.

Sample Name

Genotype

BPA exposure (mM)

Yield (# of
Paired-End Reads)

Fmr1-1a-ctl

FXS

0

83,622,076

Fmr1-1b-ctl

FXS

0

72,939,418

Fmr1-1c-ctl

FXS

0

63,084,116

mRNA-SEQUENCING PIPELINE AND PATHWAY ANALYSIS TO DETERMINE THE EFFECTS OF BISPHENOL A ON FRAGILE X SYNDROME IN DROSOPHILA MELANOGASTER

Fmr1-2a-BPA

FXS

1

79,665,398

Fmr1-2b-BPA

FXS

1

90,165,828

Fmr1-2c-BPA

FXS

1

73,257,102

WT-1a-ctl

Wild-type

0

84,643,040

WT-1b-ctl

Wild-type

0

79,250,718

WT-1c-ctl

Wild-type

0

76,534,574

WT-2a-BPA

Wild-type

1

58,611,706

WT-2b-BPA

Wild-type

1

60,458,158

WT-2c-BPA

Wild-type

1

68,449,132

9

Table 1. Raw Sequenced Data.
Table 1 described the original samples received from GeneWiz. The table showed the
genotype and the millimolar (mM) of BPA exposure for each sample of Drosophila sequenced.
The last column reported the number of paired-end reads yielded for each replicate from the
Illumina sequencer.

3.2 mRNA-Sequencing Data Analysis Pipeline
An mRNA-sequencing data analysis pipeline was designed and developed for this project
to analyze the Illumina sequencing data generated; Figure 3 showed the pipeline used in this
project. This pipeline consisted of the following parts: reading the raw data from GeneWiz and
conducting a quality check (QC) on the raw reads, trimming poor quality reads and removing
Illumina sequencing adapters, conducting a QC on the trimmed reads, aligning the reads to a
reference genome, removing duplicate reads, counting aligned reads, conducting DGE analysis
between the different samples and determining the pathways affected using GSEA and DAVID.
The reference genome used was the Drosophila genome 6.35, obtained from FlyBase, a database
containing information about Drosophila genetics and molecular biology. The full pipeline was
implemented using the Snakemake on the San José State University College of Science High
Performance Computing system, which had multiple cores and GPUs to compute the
memory-intensive programs.
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Figure 3. mRNA Sequencing Pipeline Flowchart

Quality Check
FastQC (v.0.11.8) was utilized for conducting the quality check before and after
trimming. Since the samples were given as zipped files in the .gz format, one of the options used
was --noextract which ensures that the returned files were not extracted and remained in the
zipped format. The program took in all the input files (or the sample files) and outputted the
trimmed files.
The FastQC files were then combined to generate a MultiQC report with the default
options. MultiQC (v.1.4) was a tool that summarized the outputs from numerous tools in a single
report.
Trimming Raw Reads
Fastp (v.0.12.4) was used for the trimming step, which produced two zipped folders with
the trimmed samples, an HTML file, and a JSON file. While there were several options, such as
setting the adapters’ sequences, the default options were used except for --trim_front1 and
--trim_front2, which removed the indicated number of base pairs, 15, from the front of the
input sequences. This was set to 15 because the per base sequence content of the first 15 bases in
the raw reads was different from the other bases.
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Transcript Assembly
Transcript alignment was done using STAR (v.2.7.7a). STAR had two different steps:
first, the formation of a reference genome, and second, the alignment of the reads to the
reference genome created in the first step.
For making the reference genome, the --genomeFastaFiles and --sjdbGTFfile
tags were set to reference the Drosophila genome r6.35 from FlyBase. An additional tag,
--sjdbOverhang, referring to the length of the genomic sequence to conduct splicing, was set
to 134. --sjdbOverhang was ideal at one minus the largest read length; the original length of
the reads was 150, and after trimming the length of the reads in the front by 15, the lengths of the
reads were a maximum of 135. Additionally, the --genomeSAindexNbases tag, which referred
to the length of the string used to search the genome, was set to 12 since the genome size of the
Drosophila was only 143,726,002 bases. To determine the length of the
--genomeSAindexNbases, the log2 of the genome size divided by two minus one rounded
down must be calculated.
Next, STAR was utilized to align the transcripts to the reference genome. Similar to the
previous step, the --genomeSAindexNbases was again set to 12. Since these reads were in a
zipped format, an additional command was used --readFilesCommand; this was set to
gunzip -c, which was used to unzip the gzipped files. STAR typically returned its results in a
SAM file format but could also return them in a BAM file format along with log files.
--outSAMtype was set to BAM Unsorted SortedByCoordinate, so that binary BAM files
were returned for both unsorted and sorted data (the data of the assembled reads were sorted by
coordinate). Additionally, the --outReadsUnmapped tag was added to store any unmapped
reads.
After this step, the aligned reads were returned as twelve bam files – the forward and
reverse strands were aligned on the same reference genome – sorted by their location on the
reference genome. MultiQC was used for quality check and to summarize the BAM files'
mapping statistics.
PCR Duplication Removal
Duplicates that were created in the amplification step of NGS needed to be removed to
provide a better understanding of the biological counts of the RNA. This was done using a java
program called Picard (v.2.26.10) which contained the tool, MarkDuplicates. Typically, the
--OUTPUT tag returned a BAM file which identified the duplicated reads; however, the
--REMOVE_SEQUENCING_DUPLICATES tag was added and set to true, which removed the
sequencing duplicates, and the outputted BAM files only contained reads that were not PCR
sequenced. An additional tag called --CREATE_INDEX was also used, which sorted the BAM
file by coordinates, similar to STAR.
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Counting the Reads
The number of reads per sample was counted using featureCounts (v.2.0.1). -a, -F, -t,
and -G were tags that were added related to the genome file. -a stood for the annotation file
that referenced the Drosophila genome 6.35 from FlyBase, and -F stood for the format of the
annotation file, which was .gtf for this experiment. -t was set to gene, which was responsible
for identifying what kind of information was found in the .gtf file, while -G stood for the
genome file or the fasta file. Since the reads were paired-ends, the -p tag was set. Since the reads
were used to determine the DE genes in the Drosophila, the counts were grouped according to
the genes using the -g tag, which was set to gene_id. Since the duplicates were already
removed, the tags -M, which counted the multi-mapped reads, and -O, which counted the
overlaps, were also added. Another additional tag, -C, was added to ensure that the fragments
with two ends aligned to different chromosomes were not counted, as this was not actively
captured in this experiment.
Differential Gene Expression
Using DGE analysis, different samples could be compared to each other to determine the
differences in gene expression. In this experiment, four different comparisons were conducted, as
shown in Table 2.

Table 2. Comparisons of the Different Samples
DESeq2 (v.1.36.0) was used to determine the DE genes for each of the comparisons listed
in Table 2; DESeq2 was a R (v.3.2.2) based program. The first step was to read in the count file
from featureCounts and convert it into a matrix. The DESeq2 function took in the matrix, the two
contrasting samples, the interaction between the different genotypes and the presence of BPA,
and an alpha value of 0.05. DESeq2 could also show the differences of a factor based on another
factor; therefore, the gene expression changes caused by the FMR1 mutation were “muted” to
look at the effects of BPA exposure. The results of the DESeq2 function were shrunken using the
ashr package, and then sorted according to the p-adjusted value. The subset of genes below the
0.01 p-adjusted value or the most significant genes for each of the sample contrasts were selected
for GSEA. Moreover, the original counts were also normalized, and different visualizations, such
as heatmaps and principal component analysis (PCA), were conducted to understand the
normalized count data better.
Further analysis was performed on the ranked list of genes using the online tool DAVID;
for each comparison, the proteins that these differentially expressed genes encoded were
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determined. In the first step, the ranked genes were added to the website, and the
FLYBASE_GENE_ID identifier was selected. Next, the Gene List option was selected for the
list type, and the page was submitted. On the next page, the Drosophila melanogaster species
was selected, as well as the “Show Gene List” button; the results showed the Flybase gene id, the
Ensembl gene name, and the encoding protein name. Some of the genes encoded an
uncharacterized protein. For those genes, an online search on UniProt and BLAST was
conducted to determine the potential protein that the gene could encode; this was determined by
searching other flies in the Drosophila family with similar gene sequences and the proteins that
those genes encoded.
Gene Ontology Pathways
For the contrasts with more than 200 statistically significantly DE genes (wild-type
Drosophila exposed to BPA vs. FXS Drosophila exposed to BPA and wild-type Drosophila
without BPA exposure vs. FXS Drosophila without BPA exposure), fgsea (v.1.22.0) was utilized.
For fgsea, first, the tables from the DESeq2 contrasts were read, which contained the ranked list
of genes and their log2 fold change. Next, the MSigDBR (v.7.5.1) package was called to analyze
the different GO pathways that these genes affected. Fgsea function took in the ranked genes and
the GO pathways to return a table with the affected pathways, p-values, p-adjusted values,
normalized mean enrichment scores (NES), and the leading genes that affect each pathway. This
information was tabularized and visualized using the plotGseaTable and plotEnrichment
functions.
The enrichment score (ES), which was normalized for the NES, determined the deviation
for 0 that the GSEA “walked” from 0 to get to the genes in the pathway [39]. The ranks of the
DE genes were used to determine the score; the ES increased each time the gene was in the set
and decreased each time, it was not. To determine the statistical significance, the samples were
randomly scrambled, and the ES scores were calculated each time. The actual ES was divided by
the mean ES for 1000 permutations to obtain the NES. Since the ranks that were determined
were the enriched ranks, the majority of the ES would typically fall into the negative or positive
range; a negative score indicated that the majority of the genes were down-regulated and vice
versa.
DAVID was utilized for the contrasts with fewer significantly expressed genes (wild-type
Drosophila exposed to BPA vs. wild-type Drosophila without exposure to BPA and FXS
Drosophila exposed to BPA vs. FXS Drosophila with no exposure to BPA). The steps for
DAVID were the same as for DESeq2. However, instead of selecting the ‘Show Gene List,’ the
‘Functional Annotation Tool’ was chosen. This returned clusters of affected pathways, as well as
a p-value and a p-adjusted value for each pathway.
Once the pathways from both fgsea and DAVID were returned, the individual genes from
each of the pathways were analyzed using cluster maps in Python. To generate the cluster maps,
first, the Ensembl ids and names of the genes in Drosophila were taken from the Ensemble
server using the pybiomart package and used to replace the FlyBase gene IDs from the ranked
list of DE genes from DESeq2.
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Once the gene ids were replaced with gene names, the normalized counts of each of the
samples were imported into a Python Pandas dataframe. The counts of the DE genes in each of
the pathways were then extracted into their respective dataframe. These counts were then used to
create the cluster map using the Seaborn package. One of the arguments of the cluster map
function was the z-score which was set to 0 to indicate rows; therefore, z-score calculations were
done for each row. Hence, the genes for all the selected samples were normalized using the
z-score normalization technique.

IV.

RESULTS

Raw Reads Quality
After obtaining the raw reads, quality metrics were conducted using FastQC. The FastQC
results were combined into a single report using MultiQC. Figure 4 showed the mean quality of
all of the reads for all of the samples from MultiQC; Figure 5 showed the percent of sequences
that contain adapters in all of the samples.

Figure 4. Quality Scores for Raw Reads Analyzed using MultiQC
Figure 4 showed that the reads for all of the sequences had a Phred score of greater than
or equal to 34 for all the base positions. There was a slight dip starting at base pair 100 for all the
sequences; the Phred scores were between 34 and 35 for all of the sequences at position 150.
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Figure 5. Adapter Content for Raw Reads Analyzed using MultiQC
Figure 5 showed that the adapter content reached the warning levels or above 5% of the
sequences after the 110th base of the reads for all the samples. The highest adapter content was
between 14% to 18.5% for the different samples.

Trimming Raw Reads
Fastp removed the adapter sequences, any low-quality reads, and low-quality bases in the
reads. The yielded number of paired-end reads was shown in Figure 6, as well as the percent of
reads retained from the raw reads.
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Figure 6. Bar Graph for Trimmed Reads
In Figure 6, the trimmed results showed that a minimum of 50 million reads were
retained for all of these samples. Moreover, more than 98% of the reads for each of the samples
were not removed.
Quality metrics for these trimmed reads were conducted for all samples using FastQC.
These reports were combined into a single report using MultiQC. Figure 7 showed the adapter
content for the trimmed reads, containing less than 0.2% of adapter content on average.
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Figure 7. Adapter Content for Trimmed Reads Analyzed using MultiQC

Figure 7 showed that the adapter content did not reach the warning levels or 5% of the
sequences for the samples after trimming. Moreover, the highest adapter content was between
0.1% to 0.4% for the different samples.
Due to trimming, read lengths were no longer 150 base pairs. Figure 8 showed the
trimmed length distribution of all of the reads for each of the samples in a MultiQC report.
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Figure 8. Sequence Length Distribution for Trimmed Reads Analyzed using MultiQC

Figure 8 showed that 20 to 31 million reads in all samples have a length of 135 base
pairs. However, several of the reads were shorter, with the shortest read being 46 base pairs.

Transcript Assembly
The trimmed reads were mapped to the reference Drosophila genome, r.6.35, from
Flybase. The alignment statistics from the STAR BAM files were obtained by using MultiQC,
which were shown in Figure 9.
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Figure 9. STAR Results Analyzed using MultiQC
Figure 9 showed that the majority of the reads were uniquely mapped to one loci on the
fly genome; for all the samples, at least 19 million reads were uniquely mapped. However,
several million reads for each sample were too short to be mapped, due to the short lengths of the
reads after trimming.

PCR Duplication Removal
During the PCR amplification process of NGS, the transcriptomic fragments were
duplicated, which were removed using the tool, MarkDuplicates, from Picard. One of the quality
metrics from FastQC was sequence duplication levels. Figure 10 showed the sequence
duplication levels from the MultiQC report after trimming, while Figure 11 showed the
duplication levels after the duplicates were removed.
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Figure 10. Duplication Levels for Trimmed Reads Analyzed using MultiQC

Figure 10 showed the duplication levels for the trimmed reads analyzed using MultiQC.
Before removing the duplicates, 15 to 25 percent of the samples' sequences were unique
fragments.
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Figure 11. Duplication Levels after MarkDuplicates Analyzed using MultiQC
Figure 11 showed the duplication levels for the de-duplicated reads analyzed using
MultiQC. After removing the duplicates, 64 to 67 percent of the samples' sequences were unique
fragments.
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Differential Gene Expression
The de-dupped reads were counted using featureCounts and a count file was generated.
The first step of DESeq2 was to normalize the read counts from the count file. These normalized
counts were clustered based on their gene expression profile similarity in a PCA plot, which was
shown in Figure 12.

Figure 12. Principal Component Graph of Normalized Counts
Figure 12 showed that 61% variance clearly separated the two types of samples: fmr1 (FXS
Drosophila) and wildtype (wild-type Drosophila), while 14% variance distinguished the two
conditions: bpa (exposure to BPA) and ctr (no exposure to BPA). Moreover, all of the FXS
samples clustered together regardless of BPA presence; while it was possible to cluster wild-type
with and without BPA separately, the clusters were very close to each other.
DESeq2 used the count file and conducted DGE analysis for each comparison listed in
Table 2. A summary table of all the DE genes was present in Table 3.

Comparison

# of
Down-regulated
DE Genes

# of
Up-regulated
DE Genes

Total # of DE Genes

Wild-type Drosophila with and
without BPA exposure

2

23

25

FXS Drosophila with and without
BPA exposure

0

17

17

Wild-type vs FXS Drosophila
without BPA exposure

2,334

2,833

5,167
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Wild-type vs. FXS Drosophila with
BPA exposure

593

1,206

1,799

Table 3. Number of DE Genes (p-adjusted < 0.01) for Each Comparison
Table 3 showed the total number of up-regulated and down-regulated DE genes for each
comparison. The analysis that compared the genotypes with and without BPA exposure identified
less than 50 DE genes, while the analysis that compared wild-type and FXS Drosophila for the
two conditions (with and without BPA exposure) identified thousands of DE genes.
The table (Table A1) of the DE genes for wild-type Drosophila with and without BPA
and the cluster map (Figure A1) for the normalized counts of the DE genes were located in the
appendix. Table 4 showed the DE genes for FXS Drosophila with and without BPA; the heatmap
for these DE genes was shown in Figure 13.
Potential protein
(BLAST/UniProt)

Flybase ID

Gene name

Protein name

FBgn0265152

lncRNA:CR44221

long non-coding RNA:CR44221

-

FBgn0266622

asRNA:CR45129

antisense RNA:CR45129

-

FBgn0040233

cana

CENP-ana

-

FBgn0264710

asRNA:CR43979

antisense RNA:CR43979

-

FBgn0262617

Nuak1

Nuak1 ortholog

-

FBgn0266303

asRNA:CR44968

antisense RNA:CR44968

-

FBgn0286833

CG46387

uncharacterized protein

transporter Tret1

FBgn0267631

asRNA:CR45969

antisense RNA:CR45969

-

FBgn0031170

ABCA

ATP binding cassette subfamily A -

FBgn0287614

lncRNA:CR46483

long non-coding RNA:CR46483

-

FBgn0039266

CG11791

uncharacterized protein

myotubularin-related
protein

FBgn0040950

Muc26B

Mucin 26B

-

FBgn0025455

CycT

Cyclin T

-

FBgn0031610

CG15436

uncharacterized protein

zinc finger protein

FBgn0065083

snmRNA:765

small non-messenger RNA 765

-

FBgn0037630

Ir85a

Ionotropic receptor 85a

-

FBgn0052475

mthl8

methuselah-like 8

-

Table 4. DE Genes (p-adjusted < 0.01) for FXS Drosophila with and without BPA
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Figure 13. Heatmap of the DE Genes (p-adjusted < 0.01) for FXS Drosophila with and
without BPA
Table 4 showed the Flybase gene ID for all 17 DE genes in FXS Drosophila with and
without BPA as well as their Ensembl gene ID, the protein that the gene encoded, and for the
uncharacterized proteins, the potential protein that the gene can encode by looking at BLAST
and UniProt for the gene in other flies in the Drosophila family. Seven out of the 17 DE genes
from Table 4 and Figure 13 encoded for RNA proteins. Moreover, in Figure 13, there was a clear
distinction between the Fmr1.2b.BPA replicate compared to the rest of the FXS Drosophila.
The top 25 DE genes in FXS versus wild-type Drosophila for both with and without BPA
exposure were the same. The cluster map showed the normalized counts for these DE genes in
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all the samples (Figure 14). A table with the gene names and the proteins that these genes
encoded was located in the appendix (Table A2).

Figure 14. Heatmap of the Top 25 DE Genes (p-adjusted < 0.01) for FXS vs. Wild-type
Drosophila with and without BPA exposure
Figure 14 showed that the presence of BPA did not affect the top 25 DE genes in the
sample. Therefore, to understand the impact of BPA, the differential gene expression associated
with the FMR1 mutation was “muted,” and the DE genes were analyzed. Table 5 showed the DE
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genes, and Figure 15 showed a cluster map of the samples with BPA and their z-score
normalized counts for each of these genes.

Flybase ID

Gene name

Potential protein
(BLAST/UniProt)

Protein name

FBgn0031512 CG15404

uncharacterized protein

MIP13665p

FBgn0262607 CG43133

uncharacterized protein

Secreted protein

FBgn0263207 CR43377

pseudo

n.a.

FBgn0052821 CR32821

pseudo

n.a.

FBgn0051698 CG31698

uncharacterized protein

GEO09046p1

FBgn0262808 CG43179

uncharacterized protein

GD_N
domain-containing
protein

FBgn0263211 CR43381

pseudo

n.a.

FBgn0263209 CR43379

pseudo

n.a.

FBgn0031170 ABCA

ATP binding cassette subfamily A -

FBgn0032140 CG13117

uncharacterized protein

Annexin B9

FBgn0261630 CG42713

uncharacterized protein

FI14528p

FBgn0262005 CG42823

uncharacterized protein

GEO02541p1

FBgn0004593 Eig71Ef

Ecdysone-induced gene 71Ef

-

FBgn0004594 Eig71Eg

Ecdysone-induced gene 71Eg

-

Table 5. DE Genes (p-adjusted < 0.01) for BPA Exposure when Effect of FMR1 Gene
Mutation was Muted
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Figure 15. Cluster map of the DE Genes (p-adjusted < 0.01) across FXS and Wild-type
Drosophila with exposure to BPA when Effect of FMR1 Gene Mutation was Muted

Table 5 and Figure 15 showed the DE genes that were impacted by the presence of BPA,
which was shown after the effect of FMR1 mutation was muted in the samples. Many of the
genes that were DE encoded uncharacterized proteins or were considered pseudo genes since
they encoded for nonfunctional proteins.

Gene Ontology Pathways
For the DE genes for the samples with and without BPA exposure, DAVID was utilized to
determine the affected pathways. Table 6 showed the clusters from wild-type Drosophila with
and without BPA presence; Table 7 showed the clusters from FXS Drosophila with and without
BPA presence. Cluster maps of the genes identified from the functional annotation clusters were
located in the appendix (Figure A2, A3).
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Annotation Cluster 1
Enrichment Score: 0.3429534568470218
Term

%

Fold Enrichment

Leading Genes

GO:0016021~integral component of
membrane

ImpL1, Chs2, CG7497, CG42717,
1.778 spok, CG33282

28.5714

KW-0472~Membrane

33.3333

sad, ImpL1, Chs2, CG7497,
1.3901 CG42717, spok, CG33282

TRANSMEM:Helical

28.5714

ImpL1, Chs2, CG7497, CG42717,
1.4248 spok, CG33282

KW-0812~Transmembrane

28.5714

ImpL1, Chs2, CG7497, CG42717,
0.9044 spok, CG33282

KW-1133~Transmembrane helix

19.0476

0.7242 ImpL1, Chs2, CG42717, spok

Table 6. Functional Annotation Clustering for Wild-type Drosophila with and without
exposure to BPA

Annotation Cluster 1
Enrichment Score: 0.3429534568470218
Term

%

Fold Enrichment

Leading Genes

GO:0016021~integral component of
membrane

23.5294

1.7122 CG11791, Ir85a, mthl8, ABCA

TRANSMEM:Helical

23.5294

1.6148 CG11791, Ir85a, mthl8, ABCA

KW-0472~Membrane

23.5294

1.4298 CG11791, Ir85a, mthl8, ABCA

KW-0812~Transmembrane

23.5294

1.3565 CG11791, Ir85a, mthl8, ABCA

KW-1133~Transmembrane helix

17.6471

1.2221 CG11791, Ir85a, mthl8

Table 7. Functional Annotation Clustering for FXS Drosophila with and without exposure
to BPA
Table 6 and Table 7 showed the pathways that were affected by the DE genes in the
sample with and without BPA exposure. In these tables, the second column showed the
percentage of the DE genes that were found in the pathway. The fold enrichment looked at all the
pathways and stated the likelihood that the pathway determined was DE. The leading genes in
the pathways were the DE genes for each pathway. The results from Table 6 and Table 7 showed
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that the DE pathways were the same in both wild-type and FXS Drosophila, despite having
different DE genes that affected those pathways for both comparisons.
To determine the pathways that were affected by the DE genes for the comparisons
between FXS and wild-type Drosophila, fgsea was used. For each GO subset (BP, CC, MF),
fgsea returned a list of 20 pathways for each comparison: the top 10 pathways that were
up-regulated and the top 10 pathways that were down-regulated, as well as the NES score, the
p-value, and p-adjusted values for each pathway. For this experiment, only the neurological
pathways were analyzed. The summarized list of neurological pathways, as well as their
function, was shown in Table 8 and Table 10. For each DE neurological pathway, the leading
genes in that pathway were determined, and this information was tabularized in the appendix
(Tables A3-A6). The leading genes for each of the neurological pathways were selected, and a
cluster map of the normalized counts for the leading genes for each neurological pathway was
created; they were located in the appendix (Figures A4-A13). The common leading genes in all
of the neurological pathways for each comparison were determined (shown in Tables 9 and 11),
and a cluster map was created with these overlapping leading edge genes’ normalized counts
(Figure 16 and Figure 17).

Pathway

Description

FXS Drosophila

WT Drosophila

GO BP Neurogenesis

the process where new neurons are
Down-regulated Up-regulated
formed in the brain

GO CC Axon

a thin fiber that extends from a
neuron

GO CC Presynapse

the end of an axon where
information is converted from
Down-regulated Up-regulated
electrical signals to chemical signals

GO CC Distal Axon

part of the axon which is close and
including the end of the axon

Down-regulated Up-regulated

Down-regulated Up-regulated

Table 8. Top DE Neurological Pathways from FXS vs. Wild-type Drosophila without BPA
Exposure

Table 8 showed the neurological pathways affected by the DE genes when comparing
FXS Drosophila without BPA exposure to wild-type Drosophila without BPA exposure. This
resulted in one biological process and three cellular components that were DE. The FXS
Drosophila pathways were down-regulated in these pathways compared to the wild-type
Drosophila pathways.
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Gene name
Git
Fmr1

Protein Name
G protein-coupled receptor
kinase interacting ArfGAP

Gene name
mAChR-A

Protein Name
muscarinic Acetylcholine
Receptor, A-type

Fmr1

Act42A

Actin 42A

Syx1A

Syntaxin 1A

Prosap

prosap

unc-13

unc-13

nudE

nudE

Sh

Shaker

Rab3

Rab3

Cirl

Calcium-independent receptor
for alpha-latrotoxin

Dop2R

Dopamine 2-like receptor

Cdk5alpha
sff

Cdk5 activator-like protein
sugar-free frosting

Table 9. Leading Genes in All of the Top DE Neurological Pathways from FXS vs.
Wild-type Drosophila without BPA Exposure
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Figure 16. Cluster map of the Normalized Counts of the Leading Genes in All of the Top
DE Neurological Pathways from FXS vs. Wild-type Drosophila without BPA Exposure
For the four DE neurological pathways from the FXS versus wild-type Drosophila
without BPA exposure comparisons, there were a total of 14 genes that affected all of the DE
pathways, including the Fmr1 gene as shown in Table 9. All of these 14 genes were
down-regulated in the FXS Drosophila compared to the wild-type Drosophila.
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Pathway

Description

GO BP Regulation of
Trans Synaptic
Signaling

the process that controls the
cell-cell signaling in the
synapse (junction between the
two neurons)
Down-regulated

Up-regulated

GO BP Synaptic
Signaling

the process of neuron
communication by sending a
message from one neuron to
another neuron

Down-regulated

Up-regulated

GO CC Presynapse

the neuron that sends the
information to the other neuron Down-regulated

Up-regulated

GO CC Presynaptic
Membrane

the membrane of the axon
terminal which faces the
synaptic junction

Down-regulated

Up-regulated

GO CC Presynaptic
Active Zone

location on the membrane
where the "information" is
released

Down-regulated

Up-regulated
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FXS Drosophila WT Drosophila

Table 10. Top DE Pathways from FXS vs. Wild-type Drosophila with BPA Exposure
Table 10 showed the neurological pathways affected by the DE genes when comparing
FXS Drosophila with BPA exposure to wild-type Drosophila with BPA exposure; there were two
biological processes that were DE as well as three cellular component pathways. Similar to the
comparisons without BPA exposure, the FXS Drosophila pathways were down-regulated
compared to the wild-type Drosophila pathways.
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Gene name

Protein Name

Gene name

Protein Name

Syx1A

Syntaxin 1A

Rim

Rab3 interacting molecule

unc-13

unc-13

Syt4

Synaptotagmin 4

X11Lbeta
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X11Lbeta

Table 11. Common Leading Genes from the Top DE Neurological Pathways from FXS vs.
Wild-type Drosophila with BPA Exposure

Figure 17. Cluster map of the Normalized Counts of the Leading Genes in All of the Top
DE Neurological Pathways from FXS vs. Wild-type Drosophila without BPA Exposure
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For the five DE neurological pathways from the FXS versus wild-type Drosophila with
BPA exposure comparison, there were a total of five genes that affected all of the DE pathways,
which were shown in Table 11. These five genes were down-regulated in the FXS Drosophila
compared to the wild-type Drosophila, similar to FXS versus wild-type Drosophila without BPA
exposure.
V.

DISCUSSION

5.1 mRNA Sequencing Analysis
Trimming Raw Reads
Before and after trimming, quality metrics for all the samples were taken using FastQC,
and MultiQC generated a summary report of the FastQC reports. Figure 4 showed that the
quality of the raw reads was in the green zone with a Phred score of greater than or equal to 34
for all the bases. Hence, the overall quality of the raw reads was good and minimal removal of
low-quality reads was required to improve the overall quality of all the reads in each of the
samples. This was confirmed by Figure 6, which showed that nearly 98% of the raw reads for all
the samples were retained after trimming. As mentioned earlier [31], one of the dangers of
trimming is over-trimming, leading to insufficient reads for downstream analysis. However,
Figure 6 showed that there were at least 50 million reads left for all samples to conduct
downstream analysis.
Nevertheless, Figure 5 showed 14% to 18.5% adapter content in the raw reads for the
different samples. As shown by Figure 7, fastp was able to remove the majority of adapters so
that the adapter content was between 0.1% and 0.4%. Moreover, GeneWiz gave a report which
showed the barcode (or the index used during Illumina sequencing) for the different samples. In
the report generated by fastp, these barcodes were shown to be the adapter regions that were
removed from the sequences, proving that the regions that were being analyzed downstream are
indeed the regions of interest.
PCR Duplication Removal
Since a large percentage of the reads were duplicates as shown in Figure 10, duplication
removal was conducted. The two main reasons mentioned in [23] to avoid duplication removal
were fragmentation and sample bias. One of the reasons that fragmentation was not as apparent
in this experiment was because paired-end sequencing was conducted. If fragmentation occurred
in one strand, the other strand of the pair provided the information required to determine the ends
of the fragments. Moreover, GeneWiz provided high quality reads for all of the samples as
shown in Figure 4. Furthermore, the sheer number of quality reads that were found in the
samples indicated reduced sampling bias. After the removal of duplicates, nearly 65% of the
reads for all the samples were unique fragments (Figure 11), providing a more accurate
representation of the biological system.
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Differential Gene Expression
After counting the reads, the gene counts were normalized using DESeq2 and visualized
using PCA. PCA worked by reducing the number of features involved in a dataset, while
ensuring that the least amount of information was lost. This was done by creating new features
with high variances that could account for the differences between the features in the dataset; this
allowed the “original” features to become less important and hence, removed. Overall, PCA
allowed for the retention of important information, while reducing the required number of
features [40]. One reason to conduct PCA was to determine the samples with similar features (or
gene counts) [22]. In this experiment, since there were different samples with different genotypes
(FXS and wild-type) and conditions (BPA and no BPA), the replicates for each type of sample
should cluster separately, theoretically. However, as Figure 12 showed, while the FXS and
wild-type Drosophila did cluster separately from each other, the conditions – with and without
BPA (ctr) – did not, especially the samples with the FXS genotype. This was consistent with
results found in Dr. Mulligan’s lab; for certain phenotypic metrics, FXS Drosophila had no
change or even rescue effect when exposed to BPA (Figure 18).

Figure 18. The Effects of BPA in FXS and Wild-type Drosophila Observed in a Lab Setting
Source: Adapted from [37]
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When comparing the FXS Drosophila with and without BPA exposure, 17 genes were
DE, of which seven of them encoded for RNA proteins. These RNA proteins had regulatory
purposes in gene expression at multiple levels from replication, transcription, and translation.
Hence, in FXS Drosophila, the presence of BPA affected the production of RNA proteins, which
regulated overall protein expression.
In the PCA plot, the differences between FXS and wild-type Drosophila were more
apparent than the differences between BPA and no BPA. Moreover, the different number of DE
genes for each of the comparisons were listed in Table 3; the samples that compared with and
without BPA exposure had significantly fewer DE genes than the samples that compared the two
Drosophila genotypes. Further analysis was also conducted by looking at the top 25 DE genes
for FXS versus wild-type Drosophila for both with and without BPA exposure; in both
comparisons, the same top DE genes were expressed. These results indicated that despite the
presence of BPA, the FMR1 mutation in Drosophila had a stronger effect on the samples.
Therefore, the differential gene expression associated with the FMR1 mutation was “muted”
using DESeq2 to determine the impact of BPA, and the resulting DE genes were located in Table
5. Several of these DE genes were considered pseudo genes as they no longer encoded functional
proteins; therefore, BPA caused mutations on the DNA level to stop the production of functional
proteins.
Pathway Analysis
DAVID was utilized to determine the pathways that were affected by the DE genes
resulting from the impacts of BPA exposure in the two genotypes. Despite having different
leading genes, both comparisons had the same DE pathways. These pathways were important for
building the cellular transmembrane, especially the transmembrane helix; therefore, BPA
affected the pathways that built the cell's transmembrane.
However, because there were fewer DE genes for both comparisons, DAVID was easily
influenced by the addition and deletion of a single gene, resulting in a p-adjusted value of 1 for
these pathways. Therefore, further studies will need to be done to confirm this conclusion.
Moreover, the heatmap in Figure 13 showed how one of the replicates (Fmr1.2b with
BPA) was different from the other FXS replicates with BPA. Therefore, a full comparison of all
the normalized counts for all the genes was conducted in Figure 19; Fmr1.2b clustered
differently from the other FXS samples.
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Figure 19. Heatmap of the Normalized Genes for FXS Drosophila with and without
exposure to BPA

Therefore, the Fmr1.2b replicate was removed from the count file from featureCounts
and a new DESeq2 comparison was conducted for the contrast between FXS Drosophila with
and without exposure to BPA; a new PCA was also created (Figure 20). All of the FXS
Drosophila still clustered together despite the presence of BPA. However, there were only three
DE genes – ND2, ABCA, and asRNA:CR45129 – for the FXS Drosophila with and without BPA
exposure. The results were tabularized (Table 12) and a heatmap of the normalized counts for the
DE genes was created (Figure 21). Importantly, one of the DE genes, ABCA, was studied
frequently for autism; it was predicted to be localized in the adult head [42]. It encodes a protein
that affects the membrane [42]. The DE of the ABCA gene indicated that the presence of BPA has
neurological implications in FXS Drosophila.
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Figure 20. Principal Component Graph of Normalized Counts without Fmr1.2B replicate

Flybase ID

Gene name

protein_name

FBgn0013680

ND2

mitochondrial NADH-ubiquinone oxidoreductase
chain 2

FBgn0031170

ABCA

ATP binding cassette subfamily A

FBgn0266622

asRNA:CR45129

antisense RNA:CR45129

Table 12. Differentially Expressed Genes for Fmr1 Drosophila (without Fmr1.2B replicate)
with and without BPA
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Figure 21. Heatmap of the Differentially Expressed Genes for Fmr1 Drosophila (without
Fmr1.2B replicate) with and without BPA
Neurological pathways were affected for both comparisons of FXS versus wild-type
Drosophila. In the results section, the neurological pathways that were found using fgsea were
shown in Tables 8 and 10. In FXS versus wild-type Drosophila without BPA exposure, the DE
pathways were related to the process of building new neurons and specific parts of the neuron,
such as the axon and presynapse. Meanwhile, in FXS versus wild-type Drosophila with BPA
exposure, the DE pathways affected the signaling between two neurons and the presynapse, the
part of the neuron that would specifically send information to another neuron.
As expected, the Fmr1 gene was one of the leading genes in all of these pathways when
comparing FXS and wild-type Drosophila. The Fmr1 gene regulated neural breaks by regulating
RNA trafficking and translation and affecting neuronal excitability [42]. Further analysis of the
neural pathways in FXS and wild-type Drosophila with no BPA exposure showed that there were
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14 overlapping leading edge genes in all of the affected pathways. One of the genes was the Git
gene which encoded the G protein-coupled receptor kinase; the protein was involved in synaptic
vesicle recycling, localized in the presynapse, and expressed in the adult fly head and larval
muscle system. Interestingly, the gene had an ortholog in humans which was associated with
ADHD. Several of the DE genes, such as mAChR-A, Sh, and Syx1A encoded proteins that
affected the release of neurotransmitters, while other DE genes like Prosap, unc-13, Rab3, and
Cdk5alpha encoded proteins that affected the synaptic development, homeostasis, and vesicle
exocytosis. sff or sugar-free frosting produced a protein that affected the neuromuscular junction.
Therefore, the DE genes in FXS and wild-type Drosophila with no BPA exposure affect neural
pathways found in the fly.
There were a total of five DE genes that appeared in all the neural pathways for FXS and
wild-type Drosophila with BPA exposure. Rim encoded for the Rab3 molecule, which was
required for neurotransmitter release at the synaptic active zone [42]. Syt4 encoded
Synaptotagmin 4, a calcium-dependent protein that regulated postsynaptic signaling. While the
exact purpose of X11LBeta gene was unknown, the protein was predicted to be active in the
dendritic spine and was expressed in the larval brain, nervous system, and nerve cord. Moreover,
it had orthologs to human genes – APBA1 and APBA2 – which encoded amyloid beta precursor
proteins; these proteins have had effects on Alzheimer’s disease.
Similar to the FXS and wild-type Drosophila with no BPA exposure, the Fmr1 gene is
the leading gene in several of the pathways (almost all except for one) for FXS and wild-type
Drosophila with BPA exposure. There are two DE genes – Syn1A and unc-13 – that appeared in
all the pathways for both FXS and wild-type Drosophila with BPA exposure and FXS and
wild-type Drosophila without BPA exposure. The DE pathways showed that BPA affected
neurological pathways in both FXS and wild-type Drosophila comparisons and despite the
presence of BPA, several of the same leading edge genes affected pathways in both comparisons.

5.2 Future Experiments
Currently in the lab, the impact of BPA and its analogs are being analyzed for Wildtype
Drosophila. Therefore, a potential experiment could look at the impact of the BPA analogs in
FXS Drosophila. Similarly, there is an experiment that analyzes the impact of the different
concentrations of BPA, which can similarly be conducted on FXS Drosophila.
Moreover, in this experiment, only neurological pathways were analyzed; however,
several of the pathways that were affected were related to reproduction. Therefore, how BPA
affects reproduction in FXS needs to be studied. It is important to note that this experiment needs
to be done on another model organism since Drosophila does not have estrogen receptors.
In this experiment, mRNA is being measured to determine protein expression, ribosome
profiling might provide a clearer picture of all the proteins that are truly synthesized in this
experiment. UTR regions of the mRNA which regulate protein production also need to be
understood to provide a more accurate measure of protein expression in the cell. Based on the
STAR results, parts of the reads that seem to be unmapped are part of the untranslated region of
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the mRNA. Therefore, future experimentation can look at these regions. Similarly transcriptional
factors, such as promoters and inhibitors, that affect the production of mRNA can be studied to
understand how they influence the read counts.
Lastly, understanding of how BPA might affect methylation needs to be studied. Since
FXS is caused by hypermethylation on the Fmr1 gene, the effect of BPA on hypermethylation
needs to be understood.
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APPENDIX

Potential protein
(BLAST/UniProt)

Flybase ID

Gene name

Protein name

FBgn0053282

CG33282

uncharacterized protein

transporter Tret1

FBgn0031512

CG15404

uncharacterized protein

transporter Tret1

FBgn0038239

CG14850

uncharacterized protein

transporter Tret1

FBgn0015576

alpha-Est8

alpha-Esterase-8

-

FBgn0030828

CG5162

uncharacterized protein

vitellogenin-1

FBgn0261634

CG42717

uncharacterized protein

serine protease
inhibitor

FBgn0001256

ImpL1

Ecdysone-inducible gene L1

-

FBgn0051698

CG31698

uncharacterized protein

KR084_010337

FBgn0262808

CG43179

uncharacterized protein

serine protease
inhibitor

FBgn0086917

spok

spookier

-

FBgn0261630

CG42713

uncharacterized protein

serine protease
inhibitor

FBgn0036194

Dph1

Diphthamide biosynthesis 1

-

FBgn0029170

TwdlT

TweedleT

-

FBgn0041183

Tep1

Thioester-containing protein 1

-

FBgn0029091

Chs2

Chitin synthase 2

-

FBgn0003312

sad

shadow

-

FBgn0039428

CG14237

uncharacterized protein

new-glue 1

FBgn0004594

Eig71Eg

Ecdysone-induced gene 71Eg

-

FBgn0000045

Act79B

Actin 79B

-

FBgn0034507

CG11192

uncharacterized protein

transporter Tret1

uncharacterized protein

prostaglandin D2
receptor

FBgn0036742

CG7497

Table A1. Differentially Expressed Genes for Wild-type Drosophila with and without BPA
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Figure A1. Heatmap of the Differentially Expressed Genes for Wild-type Drosophila with
and without BPA
Potential protein
(BLAST/UniProt)

Flybase ID

Gene name

Protein name

FBgn0000078

Amy-d

Amylase distal

-

FBgn0262123

l(2)41Ab

lethal

-

FBgn0085359

CG34330

uncharacterized protein

RH26422p

FBgn0033327

PGRP-SC1b

Peptidoglycan recognition protein
SC1a
-
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FBgn0043576

PGRP-SC1a

Peptidoglycan recognition protein
SC1a
-

FBgn0036414

nan

nanchung

-

FBgn0000079

Amy-p

Amylase proximal

-

FBgn0033327

PGRP-SC1b

Peptidoglycan recognition protein
SC1b
-

FBgn0043576

PGRP-SC1a

Peptidoglycan recognition protein
SC1b
-

FBgn0052212

CG32212

uncharacterized protein

cuticle protein 38

FBgn0260463

Unc-115b

Uncoordinated 115b

-

FBgn0038079

NijC

Ninjurin C

-

FBgn0004425

LysB

Lysozyme B

-

FBgn0053105

p24-2

p24-related-2

-

FBgn0041180

Tep4

Thioester-containing protein 4

-

FBgn0004428

LysE

Lysozyme E

-

FBgn0004429

LysP

Lysozyme P

-

FBgn0034335

GstE1

Glutathione S transferase E1

-

FBgn0264272

mwh

multiple wing hairs

-

FBgn0062928

hpRNA:CR33940

hairpin RNA:CR33940

-

FBgn0031560

CG16713

uncharacterized protein

serine protease
inhibitor

FBgn0265001

ppk18

pickpocket 18

-

FBgn0050104

NT5E-2

Ecto-5'-nucleotidase 2

-

48

FBgn0032144

CG17633

uncharacterized protein

zinc
carboxypeptidase A
1

FBgn0001085

fz

frizzled

-

FBgn0037930

CG14715

uncharacterized protein

peptidylprolyl
isomerase

FBgn0051352

Unc-115a

Uncoordinated 115a

-

Table A2. Top 25 Differentially Expressed Genes for Wild-type and FXS Drosophila with
and without BPA
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Figure A2. Heatmap of the Genes from the Functional Annotation Cluster for Wild-type
Drosophila with and without exposure to BPA
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Figure A3. Heatmap of the Genes from the Functional Annotation Cluster for FXS
Drosophila with and without exposure to BPA

Pathway

GOBP_NEUROGENESIS

NES

Leading Genes

Fmr1, Dscam2, BBS4, cas, futsch, dtn, CG13287, stan,
Slc25A46b, pros, smal, drl, Nf1, PDZ-GEF, toy, onecut, Art4,
-2.0601 IRSp53, hop, G9a, eve, otp, CG32809, robo2, BBS8, scrt, promL,
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Dab, Nmdar2, stau, spen, Iswi, lbl, unc-104, Girdin, erm, Rab3,
Dscam4, zfh1, Ziz, Uch, Zir, salr, mil, Rim, mAChR-A, Imp,
LanB2, nerfin-1, Gyf, Sin3A, Usp20-33, Frq2, Nepl17, Sox102F,
FER, LpR2, Lar, 4E-T, TTLL1B, Ars2, Kdm4B, Hey, Trim9,
Rbfox1, Nrx-1, ck, nudE, tutl, Smurf, salm, sff, CG13531, Dll,
mirr, Kdm4A, POSH, Dg, Sos, ci, babo, Ptx1, Dcr-1, Pkc98E,
Cdk5alpha, trpl, CG33111, EndoA, dlp, CG45105, cora, Chd3,
l(2)gl, unc-13, rl, Dop2R, Syx1A, Sec24AB, msn, Ptp99A, Pten,
Rhau, tho2, CG6254, Ank, CG10939, Actbeta, asp, dlg1, Pex7,
DIP2, ft, rst, jumu, ap, Efa6, Cirl, Top2, RhoGAPp190, PlexB, lbk,
dmrt99B, E(spl)mdelta-HLH, csul, Kal1, MICAL-like, eIF4E1, dpp,
LIMK1, cyc, Act42A, btv, sina, kto, Wee1, E(spl)mbeta-HLH, ptc,
Lrp4, CrebA, Git, Dsp1, faf, Src64B, Ten-m, CG9650, net, sif, Sh,
sti, nab, fd96Cb, sbb, Fak, eIF4G1, CG4393, tna, Patronin,
CG7956, mr, Khc-73, sub, en, Lcch3, Ufl1, CG12099, Sidpn, sv,
Crtc, Prosap, Ets65A, nAChRalpha5, Tor, fkh, Optix, Abl, scrib,
sli, fra, me31B, aux, Rab8, sd, Ptp10D, Tao, Nipped-B, pbl, Ser,
CG4615, Gug, ps, shi, MAN1, par-1, cwo, Cont, Unc-76, Cul4,
Eph, Megf8, JIL-1, Nrx-IV, Dap160, Dys, fus, Rat1, Grip84, mib1,
tkv, Arp2, PlexA, dock, Graf

Table A3. Neurological Pathway Analysis using GO Biological Process Database for FXS vs
Wild-type Drosophila with no exposure to BPA
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Figure A4. Heatmap of the leading genes in GOBP_Neurogenesis in GO Biological Process
Database for FXS vs Wild-type Drosophila with no exposure to BPA
Pathway

GOCC_AXON

NES

Leading Genes

Fmr1, Dscam2, futsch, Schip1, Nf1, cpx, Shaw, eve, CG32809, robo2,
Sbf, mmd, ZnT33D, stau, unc-104, Rab3, Dscam4, VAChT, Uch,
CG9098, Zir, mAChR-A, Imp, Bre1, wnd, tio, Rbp, Frq2, didum,
CG30389, unc80, Syt4, Gad1, Eaat2, Ekar, nudE, tutl, Smurf, sff,
-1.9471 CG13531, mirr, eag, Dg, RhoGAP1A, mGluR, Cdk5alpha, trpl,
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CG33111, cora, l(2)gl, unc-13, Aplip1, Dop2R, Syx1A, msn, Shab,
Rhau, Ank, GABA-B-R1, dlg1, DIP2, rst, Cirl, bchs, Gs2, lbk, Nmdar1,
Act42A, tsh, zip, ptc, Git, VGlut, faf, Ten-m, Klp3A, IA-2, CG11155, sif,
Vmat, Sh, Fak, Nab2, Cbp53E, p130CAS, CG7956, Khc-73, sub, bsk,
5-HT1A, Opa1, Prosap, ens, Abl, VGAT, fra, Ptp10D, Tao, Klp31E,
Exo70, Rab3-GEF, shi, Cont, Vps16A, Unc-76, Eph, Nrx-IV, step,
Trpm, para, Graf, Synj, CG5446, Cbl

GOCC_PRESYNAPSE

Fmr1, nSyb, Syngr, unc-13-4A, CG43066, Nf1, cpx, IRSp53, Shaw,
CG32809, X11Lbeta, mmd, CG31140, ZnT33D, Task6, Vps45,
Nmdar2, Ktl, unc-104, Rab3, VAChT, Rim, mAChR-A, Bre1, Rbp,
Rab26, Lar, Syt4, Gad1, Trim9, Eaat2, Nrx-1, Ekar, nudE, sff, eag,
mGluR, Cdk5alpha, EndoA, Gycbeta100B, unc-13, Dop2R, Syx1A,
msn, Syt12, GABA-B-R1, CG6356, dlg1, rst, Cirl, Nufip, Gs2, Oamb,
Nmdar1, Act42A, stnB, CASK, SP2353, Git, VGlut, IA-2, CG11155,
Vmat, Sh, Mctp, nAChRalpha2, Cbp53E, PIP5K59B, Tango11,
-2.0667 5-HT1A, Prosap, Pld, scrib, VGAT, tweek, aux, Rab8

GOCC_DISTAL_AXON

Fmr1, futsch, cpx, Shaw, Rab3, Dscam4, VAChT, Zir, mAChR-A, Imp,
Bre1, wnd, tio, Rbp, didum, Gad1, Ekar, nudE, sff, Cdk5alpha, trpl,
CG33111, unc-13, Dop2R, Syx1A, Cirl, Gs2, lbk, Nmdar1, Act42A,
tsh, zip, ptc, Git, VGlut, faf, Ten-m, IA-2, CG11155, sif, Vmat, Sh, Fak,
Cbp53E, sub, 5-HT1A, Prosap, Abl, VGAT, fra, Ptp10D, Tao, Klp31E,
-2.2137 Exo70

GOCC_NEURON_
PROJECTION

Fmr1, nSyb, Dscam2, BBS4, futsch, Schip1, CG42366, Nf1,
PDZ-GEF, cpx, IRSp53, Shaw, eve, CG32809, X11Lbeta, robo2, Sbf,
mmd, BBS8, ZnT33D, CG15208, promL, nAChRbeta1, Nmdar2, stau,
ninaC, CG34357, unc-104, Rab3, Dscam4, VAChT, Ziz, Uch, uri,
CG9098, Zir, mAChR-A, Imp, Bre1, CdGAPr, wnd, tio, Gyf, Rbp, Frq2,
kst, nAChRbeta2, CG14995, Lar, didum, CG30389, unc80, Syt4,
Gad1, Su(var)2-10, Trim9, Eaat2, ck, Ekar, nudE, tutl, Smurf, sff,
CG13531, orb, mirr, eag, Dg, RhoGAP1A, mGluR, Cdk5alpha, trpl,
CG33111, CG45105, cora, l(2)gl, Oseg1, unc-13, Aplip1, Dop2R,
PK2-R1, Syx1A, Ca-alpha1D, msn, Pten, Shab, Rhau, Ank,
GABA-B-R1, CG10939, dlg1, cnk, nwk, DIP2, 5PtaseI, rst, Efa6, Cirl,
bchs, Gs2, lbk, CG33096, smg, Nmdar1, LIMK1, Act42A, Kif3C, sina,
stnB, tsh, CASK, zip, ptc, Lrp4, Git, VGlut, GABA-B-R2, faf, Src64B,
Ten-m, Klp3A, Kap-alpha1, CG9650, IA-2, CG11155, sif, Vmat, Sh,
Ncc69, Fak, Nab2, nAChRalpha2, Cbp53E, Arf79F, p130CAS,
CG4393, CG7956, Khc-73, sub, Lcch3, Ufl1, Sec71, bsk, 5-HT1A,
Opa1, Crtc, Prosap, ens, nAChRalpha5, Tor, Abl, VGAT, CG9328, fra,
CG12909, Rab8, Ptp10D, Tao, Klp31E, CG44422, Exo70, Rab3-GEF,
CycG, shi, sqd, par-1, Cont, Vps16A, Hrb87F, Unc-76, Eph, Nrx-IV,
-1.9406 Dap160, Dys
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Table A4. Neurological Pathway Analysis using GO Cellular Components for FXS vs
Wild-type Drosophila with no exposure to BPA

Figure A5. Heatmap of the leading genes in GOCC_AXON in GO Cellular Components for
FXS vs Wild-type Drosophila with no exposure to BPA
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Figure A6. Heatmap of the leading genes in GOCC_PRESYNAPSE in GO Cellular
Components for FXS vs Wild-type Drosophila with no exposure to BPA
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Figure A7. Heatmap of the leading genes in GOCC_DISTAL_AXON in GO Cellular
Components for FXS vs Wild-type Drosophila with no exposure to BPA
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Figure A8. Heatmap of the leading genes in GOCC_NEURON_PROJECTION in GO
Cellular Components for FXS vs Wild-type Drosophila with no exposure to BPA

Pathway
GOBP_REGULATION_OF_TRANS
_SYNAPTIC_SIGNALING

NES

Leading Genes

Fmr1, PK2-R1, Rim, Appl, rl, cpx, sff, cac, unc-13-4A,
-2.9292 Syt4, X11Lbeta, Pkc98E, dysf, mnd, mGluR,
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nAChRalpha2, unc-13, Prosap, Gs2, CASK, Syx1A, tsh,
CG9328

GOBP_SYNAPTIC_SIGNALING

Fmr1, PK2-R1, CG17760, Rim, Appl, rl, cpx, sff, Shaw,
cac, unc-13-4A, Syt4, VAChT, X11Lbeta, Pkc98E, Vmat,
dysf, mnd, Task6, mGluR, Rph, nAChRalpha2, unc-13,
Prosap, Rbp, Gs2, Sh, CASK, Syx1A, tsh, CG9328, tmod,
-2.8801 msn, IA-2, Pten, Rab8, neur

Table A5. Neurological Pathway Analysis using GO Biological Process for FXS vs
Wild-type Drosophila with exposure to BPA
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Figure A9. Heatmap of the leading genes in
GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING for FXS vs Wild-type
Drosophila with exposure to BPA
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Figure A10. Heatmap of the leading genes in GOBP_SYNAPTIC_SIGNALING for FXS vs
Wild-type Drosophila with exposure to BPA

Pathway
GOCC_PRESYNAPTIC_ACTIVE_ZONE

NES

Leading Genes

Rim, Appl, sff, Syt4, X11Lbeta, unc-13,
-2.3084 Prosap, Syx1A
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GOCC_PRESYNAPTIC_MEMBRANE

GOCC_PRESYNAPSE

Fmr1, mmd, Rim, Shaw, Syt4, X11Lbeta,
mGluR, nAChRalpha2, unc-13, Sh, CASK,
-2.4001 Syx1A
Fmr1, mmd, Rim, Appl, cpx, sff, Shaw,
unc-13-4A, Syt4, VAChT, X11Lbeta, Vmat,
Task6, CG31140, mGluR, Rph,
nAChRalpha2, unc-13, Prosap, Rbp, Gs2,
-2.318 Sh, CASK, Syx1A

Table A6. Neurological pathway analysis using GO Cellular Components for FXS vs
Wild-type Drosophila with exposure to BPA
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Figure A11. Heatmap of the leading genes in GOCC_PRESYNAPTIC_ACTIVE_ZONE for
FXS vs Wild-type Drosophila with exposure to BPA
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Figure A12. Heatmap of the leading genes in GOCC_PRESYNAPTIC_MEMBRANE for
FXS vs Wild-type Drosophila with exposure to BPA
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Figure A13. Heatmap of the leading genes in GOCC_PRESYNAPSE for FXS vs Wild-type
Drosophila with exposure to BPA

